Controlled release of artemisone for the treatment of experimental cerebral malaria

BACKGROUND: Cerebral malaria (CM) is a leading cause of malarial mortality resulting from infection by Plasmodium falciparum. Treatment commonly involves adjunctive care and injections or transfusion of artemisinins. All artemisinins that are in current use are metabolized to dihydroxyartemisinin (D...

Descripción completa

Detalles Bibliográficos
Autores principales: Golenser, Jacob, Buchholz, Viola, Bagheri, Amir, Nasereddin, Abed, Dzikowski, Ron, Guo, Jintao, Hunt, Nicholas H., Eyal, Sara, Vakruk, Natalia, Greiner, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333427/
https://www.ncbi.nlm.nih.gov/pubmed/28249591
http://dx.doi.org/10.1186/s13071-017-2018-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5333427/
https://www.ncbi.nlm.nih.gov/pubmed/28249591
http://dx.doi.org/10.1186/s13071-017-2018-7

Ejemplares similares